The dangers associated with metal-on-metal hip implant devices have already prompted thousands of lawsuits in Illinois and across the country. Now regulators are taking a closer look, ordering implant makers to further study the safety of their devices.
The Food and Drug Administration is primarily concerned with metal particles that may be shed into a patient’s bloodstream, causing heart, nervous system, or thyroid gland problems. The agency is seeking more scientific data on the frequency, timing, and severity of these adverse reactions.
Early failure rates and severe health problems led DePuy Orthopedics, a division of Johnson &Johnson, to recall nearly 100,000 of its metal-on-metal hip implants back in August. DePuy is one of more than 20 manufacturers ordered to comply with the FDA’s request.
It is rare for the agency to require additional studies after a product has already hit the market. But most hip implants were approved for sale before they were properly tested, resulting in serious consequences. Although it may be too late for some patients who have already suffered the debilitating effects of a defective device, these studies may help to prevent future harm.
Long before regulators stepped in, Illinois medical malpractice attorneys at Pintas & Mullins have been investigating the adverse consequences that metal-on-metal hip implant patients have suffered. Our hip implant lawyers will continue to work tirelessly on behalf of those who have been injured by a defective device.